William Blair & Company
BDSI

William Blair & Company’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

William Blair & Company’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-463,083
Closed -$1.44M – 2051
2021
Q4 		$1.44M Sell
463,083
-239,060
-34% -$804K ﹤0.01% 822
2021
Q3 		$2.54M Sell
702,143
-9,093
-1% -$34.3K 0.01% 639
2021
Q2 		$2.55M Sell
711,236
-281,533
-28% -$993K 0.01% 633
2021
Q1 		$3.88M Sell
992,769
-26,408
-3% -$109K 0.01% 512
2020
Q4 		$4.28M Buy
1,019,177
+44,644
+5% +$172K 0.02% 471
2020
Q3 		$3.63M Buy
974,533
+34,579
+4% +$147K 0.02% 461
2020
Q2 		$4.1M Buy
939,954
+16,428
+2% +$73.8K 0.02% 419
2020
Q1 		$3.5M Sell
923,526
-1,229
-0.1% -$6.04K 0.02% 402
2019
Q4 		$5.84M Buy
924,755
+27,410
+3% +$161K 0.03% 364
2019
Q3 		$3.78M Buy
897,345
+49,425
+6% +$211K 0.02% 432
2019
Q2 		$3.94M Sell
847,920
-9,675
-1% -$45K 0.02% 423
2019
Q1 		$4.54M Buy
857,595
+56,125
+7% +$256K 0.03% 390
2018
Q4 		$2.96M Buy
801,470
+13,625
+2% +$47.9K 0.02% 435
2018
Q3 		$2.21M Buy
787,845
+80,975
+11% +$227K 0.01% 543
2018
Q2 		$2.08M Buy
706,870
+54,345
+8% +$129K 0.01% 548
2018
Q1 		$1.47M Sell
652,525
-839,830
-56% -$1.97M 0.01% 615
2017
Q4 		$4.4M Sell
1,492,355
-6,242
-0.4% -$17.3K 0.03% 385
2017
Q3 		$4.42M Buy
1,498,597
+27,475
+2% +$83.7K 0.03% 364
2017
Q2 		$4.12M Buy
1,471,122
+777,941
+112% +$1.64M 0.03% 389
2017
Q1 		$1.39M Buy
693,181
+189,484
+38% +$365K 0.01% 622
2016
Q4 		$881K Sell
503,697
-167,100
-25% -$341K 0.01% 676
2016
Q3 		$1.81M Buy
670,797
+215,079
+47% +$546K 0.02% 514
2016
Q2 		$1.07M Sell
455,718
-81,285
-15% -$224K 0.01% 618
2016
Q1 		$1.73M Sell
537,003
-33,900
-6% -$125K 0.02% 488
2015
Q4 		$2.73M Sell
570,903
-115,320
-17% -$654K 0.03% 402
2015
Q3 		$3.81M Buy
686,223
+90,762
+15% +$670K 0.03% 370
2015
Q2 		$4.74M Buy
595,461
+142,586
+31% +$1.23M 0.01% 1090
2015
Q1 		$4.75M Buy
452,875
+218,810
+93% +$2.99M 0.01% 1054
2014
Q4 		$2.81M Buy
234,065
+39,700
+20% +$603K ﹤0.01% 1193
2014
Q3 		$3.32M Sell
194,365
-14,735
-7% -$214K 0.01% 1119
2014
Q2 		$2.52M Buy
209,100
+187,250
+857% +$1.78M ﹤0.01% 1188
2014
Q1 		$184K Sell
21,850
-14,000
-39% -$113K ﹤0.01% 1913
2013
Q4 		$211K Sell
35,850
-51,450
-59% -$265K ﹤0.01% 1867
2013
Q3 		$474K Sell
87,300
-9,100
-9% -$43.8K ﹤0.01% 1564
2013
Q2 		$391K Buy
+96,400
New +$452K ﹤0.01% 1583

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

William Blair & Company's BDSI Position: Q1 2022 in Review

William Blair & Company sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 463,083 shares — an estimated $1.44M sold.

William Blair & Company first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $5.84M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • William Blair & Company reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • William Blair & Company sold 463,083 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.44M.
  • William Blair & Company first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
  • William Blair & Company's BioDelivery Sciences International, Inc. position peaked at $5.84M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.